<p align="left" style="text-align: left;"><strong><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 18pt;"><br></span></strong></p> <p align="left" style="text-align: left;"><strong><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 18pt;">글로벌 주요기업들의 바이오의약품 CDMO 추진동향</span></strong></p><strong> <p><br></p> <p><br></p></strong> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif;"> <span style="color: rgb(51, 51, 51); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 나눔고딕, NanumGothic, sans-serif; font-size: 14.66px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">-------------------------------------------------------------------------------------------------------------------</span></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;"><strong>◇ 글로벌 바이오의약품 시장이 증가함에 따라 위탁개발생산(CDMO) 시장도 급성장 중</strong></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;">- CDMO는 바이오의약품 연구개발, 임상, 생산 단계에서 특화된 서비스 제공</span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;"><br></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;"><strong>◇ 바이오의약품 CDMO 사업 진출과 확장을 위해 적극적인 외부 기술도입 및 M&A 추진</strong></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;">- 내부에서는 선택과 집중을 통한 체질개선, 외부에서는 기술도입 및 M&A를 통한 외적 성장</span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;"><br></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;"><strong>◇ 기존 항체의약품 이외에 세포치료제, 유전자치료제 CDMO로의 공격적인 투자 확대</strong></span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;">- 론자, 카탈렌트, 후지필름 등 주요기업 대부분은 세포․유전자치료제에 신규 투자</span></p> <p><span style="font-family: '나눔고딕',NanumGothic,Sans-serif; font-size: 11pt;">- 대륙 각지에 시설 확충. 써모피셔, 베링거인겔하임 등은 특히 중국에 대한 투자 확대</span></p> <p><span style="color: rgb(51, 51, 51); text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 나눔고딕, NanumGothic, sans-serif; font-size: 14.66px; font-style: normal; font-weight: 400; word-spacing: 0px; float: none; display: inline !important; white-space: normal; orphans: 2; widows: 2; background-color: rgb(255, 255, 255); font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;">-------------------------------------------------------------------------------------------------------------------</span></p> <p><br></p> <p>자세한 사항은 첨부 파일을 참고하시기 바랍니다.<br> </p>
소스입니다. Ctrl+C를 눌러 클립보드로 복사하세요

닫기